Torsten Greif



BUSINESS PUNK: Four 20 Pharma CEO Torsten Greif is one of " most interesting German minds„

Essen/Paderborn, February 13, 2024 - The founder and CEO of Four 20 Pharma GmbH, Torsten Greif, is one of the 100 German movers and shakers of the future: the Essen-based multi-entrepreneur has received an award in the XX category of the highly regarded watch list of the business magazine BUSINESS PUNK. His vision of building one of Germany's leading medical cannabis companies in terms of quality and availability and his entrepreneurial courage impressed the expert jury.

For Torsten Greif, founder and CEO of Four 20 Pharma, the year 2024 begins with an award: the renowned business lifestyle magazine BUSINESS PUNK has included him on its well-known watch list. The head of one of the leading manufacturers of medical cannabis in Europe thus joins the list of 100 founders, creatives, strategists and forward thinkers who the expert jury believes will really make a difference this year. He ranks alongside star DJ Robin Schulz and BUNTE.de editor-in-chief Alina Bähr, among others, in the “out-of-the-box thinkers” category.

The expert judges became aware of the Paderborn native because he resolutely pursues a clear goal: To change the perception of cannabis away from a drug and towards a medicine in order to help chronically ill people. The 42-year-old is also resolutely pursuing new, unconventional paths - for example in marketing, where Four 20 Pharma is the first cannabis company to sponsor a European professional football club. At the same time, he is committed to the sensible implementation of legalization and was even involved in the political consultations on the subject.

“BUSINESS PUNK's Watchlist has honored numerous innovators and thought leaders in the past. To now be on this list with a company from the cannabis industry shows that we are on the right track and that the public perception of the topic is changing,” says Greif about his award.

He is on the list together with stock market drivers such as zalando founder Robert Gentz, top investors such as Carsten Maschmeyer and influencers such as Alisa Jahnke, founder of the jewelry and lifestyle brand Purelei. They are all united by their clear vision, which they pursue with great passion. In Torsten Greif's case, this is the desire to help sick people lead a better life again.

Entrepreneur through and through

Even before founding Four 20 Pharma in 2018, Greif stood out as an entrepreneur with a flair for innovative business models. After successfully completing his studies in 2004 as one of the youngest graduates in Europe, he gained experience in sales at the leading auditing firm Deloitte, among others. He then invested in various sectors and was (co-)founder of companies in the real estate, renewable energy and gaming chair sectors.

After founding Four 20 Pharma in 2018, the father of the family also took over operational management together with Thomas Schatton in 2021. Just one year later, the company underlined its leading position in the industry by selling 55% of its shares to the world's largest cannabis company, Curaleaf Holdings from the USA.

>>>You can find Torsten Greif's complete CV here <<<

The entrepreneur has ambitious goals for 2024: “For me, it's about consolidating Four 20 Pharma's position as the market leader in Germany and transferring this success to the other European countries where we are already active,” says Greif. He also wants to continue to fight against the stigma of cannabis as a drug: “I am particularly keen to highlight the medical potential of this fascinating plant. The countless therapeutic successes for a wide range of medical conditions are not yet being communicated to the general public. I want to change that.”

You can find the complete watchlist in the current issue (01/2024) of BUSINESS PUNK, and online.

The business lifestyle magazine BUSINESS PUNK was founded in 2009 and is published six times a year with a print run of 35,000 copies. It portrays thought leaders and rebels in the business world and reports on ideas, innovations and trends. Great success stories of a young generation of entrepreneurs are mixed with the pop culture of the digital age. The Watchlist, which honors the 100 most interesting minds of tomorrow, has been published since 2017.

About Four 20 Pharma GmbH
Founded in 2018 by Thomas Schatton, Torsten Greif, Wilhelm Schoening and Ireneusz Storm in Paderborn, Four 20 Pharma GmbH is already the leading manufacturer of medicinal cannabis in Europe. The company exclusively supplies unirradiated, hand-processed and gently dried flowers in the gold standard. This means that the products far exceed the specified production requirements.

At Four 20 Pharma, the well-being of patients comes first. That is why the company has made it its mission to ensure the supply of high-quality medical cannabis so that doctors can offer patients the best possible treatment options. In order to live up to this claim, Four 20 Pharma is carrying out massive educational work on the effectiveness of the cannabis plant, which is still associated with traditional stigmas and prejudices.

Four 20 Pharma has grown rapidly in recent years and is now part of Curaleaf Holdings, the world's largest provider of cannabis consumer products with more than 6,000 employees in 21 US states. Curaleaf has owned 55 percent of the Four 20 Pharma shares since September 2022. Thomas Schatton and Torsten Greif are still active today as managing directors (CEO) and are responsible for around 60 employees at the company headquarters in Paderborn. The Paderborn-based company is now active in five European markets: Germany, the UK, the Czech Republic, Switzerland and Poland

Your PR contacts:
Henrik Lerch
+49 (0)173 592 78 18

Milena Ochsmann
+49 (0)201 890 631 992

Your professional contact:

Four 20 Pharma GmbH
Lukas Schildt
+49 (0)1571 280 985 67